首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >PNAS Plus: Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution
【2h】

PNAS Plus: Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution

机译:PNAS Plus:单个肿瘤中极高的遗传多样性表明非达尔文细胞进化盛行

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The prevailing view that the evolution of cells in a tumor is driven by Darwinian selection has never been rigorously tested. Because selection greatly affects the level of intratumor genetic diversity, it is important to assess whether intratumor evolution follows the Darwinian or the non-Darwinian mode of evolution. To provide the statistical power, many regions in a single tumor need to be sampled and analyzed much more extensively than has been attempted in previous intratumor studies. Here, from a hepatocellular carcinoma (HCC) tumor, we evaluated multiregional samples from the tumor, using either whole-exome sequencing (WES) (n = 23 samples) or genotyping (n = 286) under both the infinite-site and infinite-allele models of population genetics. In addition to the many single-nucleotide variations (SNVs) present in all samples, there were 35 “polymorphic” SNVs among samples. High genetic diversity was evident as the 23 WES samples defined 20 unique cell clones. With all 286 samples genotyped, clonal diversity agreed well with the non-Darwinian model with no evidence of positive Darwinian selection. Under the non-Darwinian model, MALL (the number of coding region mutations in the entire tumor) was estimated to be greater than 100 million in this tumor. DNA sequences reveal local diversities in small patches of cells and validate the estimation. In contrast, the genetic diversity under a Darwinian model would generally be orders of magnitude smaller. Because the level of genetic diversity will have implications on therapeutic resistance, non-Darwinian evolution should be heeded in cancer treatments even for microscopic tumors.
机译:关于肿瘤细胞进化是由达尔文选择驱动的普遍观点从未经过严格测试。由于选择极大地影响了肿瘤内遗传多样性的水平,因此重要的是评估肿瘤内进化是遵循达尔文式还是非达尔文式的进化模式。为了提供统计能力,与以前的肿瘤内研究相比,需要对单个肿瘤中的许多区域进行更广泛的采样和分析。在这里,我们从肝细胞癌(HCC)的肿瘤中,使用全外显子测序(WES)(n = 23个样本)或基因分型(n = 286)在无限位点和无限位点下评估了肿瘤的多区域样本。人口遗传学的等位基因模型。除了所有样品中存在许多单核苷酸变异(SNV)外,样品中还有35个“多态” SNV。由于23个WES样品定义了20个独特的细胞克隆,因此遗传多样性高。在对所有286个样本进行基因分型后,克隆多样性与非达尔文模型非常吻合,没有证据表明达尔文选择是积极的。在非达尔文模型下,该肿瘤中的MALL(整个肿瘤中编码区突变的数量)估计大于1亿。 DNA序列揭示了小块细胞中的局部多样性并验证了估计。相反,达尔文模型下的遗传多样性通常要小几个数量级。由于遗传多样性的水平将影响治疗抵抗力,因此,即使对于微观肿瘤,在癌症治疗中也应注意非达尔文进化论。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号